Jacint Sala-Padró
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jacint Sala-Padró has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Mercè Falip
Epilepsy Unit, Neurology Department Hospital Universitari Bellvitge L'Hospitalet de Llobregat Spain
3 shared publications - Beliu García-Parra
Clinical Neurophysiology Section - Neurology Service. Bellvitge University Hospital. L'Hospitalet de Llobregat, Spain
2 shared publications - Jordi Pedro
Neurology Service, Neurophysiology Department, Hospital Universitari de Bellvitge-IDIBELL, Universitat de Barcelona, 08908 L’Hospitalet de Llobregat, Barcelona, Spain
2 shared publications - Misericordia Veciana de Las Heras
Neurophysiology Unit, Neurology Department, Hospital Universitari de Bellvitge, Feixa Llarga, 08907 L'Hospitalet de Llobregat, Barcelona, Spain
2 shared publications - Pablo Naval-Baudin
Radiology Department, Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Carrer de Feixa Llarga SN, Barcelona, Spain
2 shared publications - Aleix Rosselló
Department of Neurosurgery, Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat, 08907 Barcelona, Spain
1 shared publication
Latest Publications
- Open Access
- 4 March 2026
- Published by Wiley in European Journal of Neurology
- Vol. 33 (3) , e70533
Impact of Treatment Delays in Epileptic Seizures
Background: Delays in the provision of care to patients experiencing seizures can result in evolution into status epilepticus (SE) and admission to the intensive care unit (ICU). However, data on specific response times and its implications remain sparse. Our aim is to report the time intervals of care delivery in patients with urgent seizures and evaluate its impact on the diagnosis of SE and the requirement for ICU admission. Methods: A consecutive cohort analysis was conducted across two tertiary hospitals between December 2022 and March 2024. Of 1493 emergency episodes, 1139 cases were analyzed after excluding non‐epilepsy diagnoses and incomplete data. Demographic data and time intervals (seizure onset, extra‐hospital emergency activation, hospital admission, and EEG performance) were recorded. Associations between these intervals and SE diagnosis or ICU admission were evaluated. Results: From our sample, 236 patients were diagnosed with SE, and 128 required ICU admission. Patients with SE had longer commute times (55 vs. 48 min, p = 0.040) and higher rates of prehospital anti‐seizure drug administration ( p < 0.001). Delays in EEG acquisition were associated with increased ICU admissions (22.1 vs. 16.5 h, p < 0.001). In multivariable analysis, prehospital treatment showed a strong association with SE (OR = 24.5, p < 0.001). Commute to hospital (OR = 4.95, p < 0.001) and seizure‐to‐EEG timelapse (OR = 5.05, p < 0.001) were associated with ICU admission. Conclusion: Pre‐hospital treatment administration, commute home to hospital and delayed EEG acquisition are associated with SE diagnosis and ICU admission, underscoring the need to optimize urgent care protocols for epileptic seizures.
- 4 March 2026
- Published by Wiley in European Journal of Neurology
- Vol. 33 (3) , e70533
Open AccessImpact of Treatment Delays in Epileptic Seizures
Background: Delays in the provision of care to patients experiencing seizures can result in evolution into status epilepticus (SE) and admission to the intensive care unit (ICU). However, data on specific response times and its implications remain sparse. Our aim is to report the time intervals of care delivery in patients with urgent seizures and evaluate its impact on the diagnosis of SE and the requirement for ICU admission. Methods: A consecutive cohort analysis was conducted across two tertiary hospitals between December 2022 and March 2024. Of 1493 emergency episodes, 1139 cases were analyzed after excluding non‐epilepsy diagnoses and incomplete data. Demographic data and time intervals (seizure onset, extra‐hospital emergency activation, hospital admission, and EEG performance) were recorded. Associations between these intervals and SE diagnosis or ICU admission were evaluated. Results: From our sample, 236 patients were diagnosed with SE, and 128 required ICU admission. Patients with SE had longer commute times (55 vs. 48 min, p = 0.040) and higher rates of prehospital anti‐seizure drug administration ( p < 0.001). Delays in EEG acquisition were associated with increased ICU admissions (22.1 vs. 16.5 h, p < 0.001). In multivariable analysis, prehospital treatment showed a strong association with SE (OR = 24.5, p < 0.001). Commute to hospital (OR = 4.95, p < 0.001) and seizure‐to‐EEG timelapse (OR = 5.05, p < 0.001) were associated with ICU admission. Conclusion: Pre‐hospital treatment administration, commute home to hospital and delayed EEG acquisition are associated with SE diagnosis and ICU admission, underscoring the need to optimize urgent care protocols for epileptic seizures.
- Open Access
- 20 September 2024
- Published by MDPI AG in Brain Sciences
- Vol. 14 (9) , 939
Utility of Quantitative EEG in Neurological Emergencies and ICU Clinical Practice
The electroencephalogram (EEG) is a cornerstone tool for the diagnosis, management, and prognosis of selected patient populations. EEGs offer significant advantages such as high temporal resolution, real-time cortical function assessment, and bedside usability. The quantitative EEG (qEEG) added the possibility of long recordings being processed in a compressive manner, making EEG revision more efficient for experienced users, and more friendly for new ones. Recent advancements in commercially available software, such as Persyst, have significantly expanded and facilitated the use of qEEGs, marking the beginning of a new era in its application. As a result, there has been a notable increase in the practical, real-world utilization of qEEGs in recent years. This paper aims to provide an overview of the current applications of qEEGs in daily neurological emergencies and ICU practice, and some elementary principles of qEEGs using Persyst software in clinical settings. This article illustrates basic qEEG patterns encountered in critical care and adopts the new terminology proposed for spectrogram reporting.
- 20 September 2024
- Published by MDPI AG in Brain Sciences
- Vol. 14 (9) , 939
Open AccessUtility of Quantitative EEG in Neurological Emergencies and ICU Clinical Practice
The electroencephalogram (EEG) is a cornerstone tool for the diagnosis, management, and prognosis of selected patient populations. EEGs offer significant advantages such as high temporal resolution, real-time cortical function assessment, and bedside usability. The quantitative EEG (qEEG) added the possibility of long recordings being processed in a compressive manner, making EEG revision more efficient for experienced users, and more friendly for new ones. Recent advancements in commercially available software, such as Persyst, have significantly expanded and facilitated the use of qEEGs, marking the beginning of a new era in its application. As a result, there has been a notable increase in the practical, real-world utilization of qEEGs in recent years. This paper aims to provide an overview of the current applications of qEEGs in daily neurological emergencies and ICU practice, and some elementary principles of qEEGs using Persyst software in clinical settings. This article illustrates basic qEEG patterns encountered in critical care and adopts the new terminology proposed for spectrogram reporting.
- Open Access
- 24 September 2021
- Published by Morressier GmbH
A practical fMRI protocol for assessing memory in mesial-temporal epilepsy surgery candidates: description of activation patterns
Introduction: Memory loss is one of the main sequelae of anterior temporal lobe resection, affecting approximately 25 - 33% of patients. Language lateralization techniques such as Wada or language functional MRI (fMRI), have proven to predict language and memory outcomes to some degree. Memory fMRI has been proposed, with good though varied results. However, there is no general
- 24 September 2021
- Published by Morressier GmbH
Open AccessA practical fMRI protocol for assessing memory in mesial-temporal epilepsy surgery candidates: description of activation patterns
Introduction: Memory loss is one of the main sequelae of anterior temporal lobe resection, affecting approximately 25 - 33% of patients. Language lateralization techniques such as Wada or language functional MRI (fMRI), have proven to predict language and memory outcomes to some degree. Memory fMRI has been proposed, with good though varied results. However, there is no general
- Open Access
- 8 September 2021
- Published by MDPI AG in Brain Sciences
- Vol. 11 (9) , 1182
Risk of Developing Epilepsy after Autoimmune Encephalitis
Background: Acute symptomatic seizures (ASS) are a common manifestation of autoimmune encephalitis (AE), but the risk of developing epilepsy as a sequela of AE remains unknown, and factors predisposing the development of epilepsy have not been fully identified. Objective: To assess the risk of developing epilepsy in AE and study related risk factors. Materials and methods: This was a retrospective single centre study including patients diagnosed with AE according to criteria described by Graus et al., with a minimum follow-up of 12 months after AE resolution. The sample was divided according to whether patients developed epilepsy or not. Results: A total of 19 patients were included; 3 (15.8%) had AE with intracellular antibodies, 9 (47.4%) with extracellular antibodies, and 7 (36.8%) were seronegative. During follow-up, 3 patients (15.8%) died, 4 (21.1%) presented relapses of AE, and 11 (57.89%) developed epilepsy. There was a significant association between the development of epilepsy and the presence of hippocampal atrophy in control brain magnetic resonance imaging (MRI) (p = 0.037), interictal epileptiform discharges (IED) on control electroencephalogram (EEG) (p = 0.045), and immunotherapy delay (p = 0.016). Conclusions: Hippocampal atrophy in neuroimaging, IED on EEG during follow-up, and immunotherapy delay could be predictors of the development of epilepsy in patients with AE.
- 8 September 2021
- Published by MDPI AG in Brain Sciences
- Vol. 11 (9) , 1182
Open AccessRisk of Developing Epilepsy after Autoimmune Encephalitis
Background: Acute symptomatic seizures (ASS) are a common manifestation of autoimmune encephalitis (AE), but the risk of developing epilepsy as a sequela of AE remains unknown, and factors predisposing the development of epilepsy have not been fully identified. Objective: To assess the risk of developing epilepsy in AE and study related risk factors. Materials and methods: This was a retrospective single centre study including patients diagnosed with AE according to criteria described by Graus et al., with a minimum follow-up of 12 months after AE resolution. The sample was divided according to whether patients developed epilepsy or not. Results: A total of 19 patients were included; 3 (15.8%) had AE with intracellular antibodies, 9 (47.4%) with extracellular antibodies, and 7 (36.8%) were seronegative. During follow-up, 3 patients (15.8%) died, 4 (21.1%) presented relapses of AE, and 11 (57.89%) developed epilepsy. There was a significant association between the development of epilepsy and the presence of hippocampal atrophy in control brain magnetic resonance imaging (MRI) (p = 0.037), interictal epileptiform discharges (IED) on control electroencephalogram (EEG) (p = 0.045), and immunotherapy delay (p = 0.016). Conclusions: Hippocampal atrophy in neuroimaging, IED on EEG during follow-up, and immunotherapy delay could be predictors of the development of epilepsy in patients with AE.